The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gyn malignancies Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Sunday, December 28, 2008

The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gyn malignancies



The safety and efficacy of day 1 versus day 2 admi...[Gynecol Oncol. 2008] - PubMed Result

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.